Compile Data Set for Download or QSAR
Report error Found 145 Enz. Inhib. hit(s) with all data for entry = 11870
TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655843(US20240067631, Compound 4)
Affinity DataEC50:  106nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655803(US20240067631, Compound 1)
Affinity DataEC50:  131nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655853(US20240067631, Compound 14)
Affinity DataEC50:  156nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655841(US20240067631, Compound 2)
Affinity DataEC50:  156nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655847(US20240067631, Compound 8)
Affinity DataEC50:  182nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655850(US20240067631, Compound 11)
Affinity DataEC50:  282nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655846(US20240067631, Compound 7)
Affinity DataEC50:  326nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655854(US20240067631, Compound 15)
Affinity DataEC50:  390nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655865(US20240067631, Compound 26)
Affinity DataEC50:  429nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655844(US20240067631, Compound 5)
Affinity DataEC50:  449nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655858(US20240067631, Compound 19)
Affinity DataEC50:  500nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655851(US20240067631, Compound 12)
Affinity DataEC50:  514nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655849(US20240067631, Compound 10)
Affinity DataEC50:  520nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655856(US20240067631, Compound 17)
Affinity DataEC50:  549nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655860(US20240067631, Compound 21)
Affinity DataEC50:  550nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655857(US20240067631, Compound 18)
Affinity DataEC50:  597nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655874(US20240067631, Compound 35)
Affinity DataEC50:  617nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655855(US20240067631, Compound 16)
Affinity DataEC50:  621nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655848(US20240067631, Compound 9)
Affinity DataEC50:  633nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655842(US20240067631, Compound 3)
Affinity DataEC50:  653nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655869(US20240067631, Compound 30)
Affinity DataEC50:  741nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655863(US20240067631, Compound 24)
Affinity DataEC50:  770nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655897(US20240067631, Compound 58)
Affinity DataEC50:  788nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655882(US20240067631, Compound 43)
Affinity DataEC50:  827nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655859(US20240067631, Compound 20)
Affinity DataEC50:  848nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655864(US20240067631, Compound 25)
Affinity DataEC50:  872nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655875(US20240067631, Compound 36)
Affinity DataEC50:  882nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655871(US20240067631, Compound 32)
Affinity DataEC50:  929nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655876(US20240067631, Compound 37)
Affinity DataEC50:  1.19E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655879(US20240067631, Compound 40)
Affinity DataEC50:  1.27E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655867(US20240067631, Compound 28)
Affinity DataEC50:  1.36E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655895(US20240067631, Compound 56)
Affinity DataEC50:  1.37E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655872(US20240067631, Compound 33)
Affinity DataEC50:  1.38E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655878(US20240067631, Compound 39)
Affinity DataEC50:  1.51E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655870(US20240067631, Compound 31)
Affinity DataEC50:  1.61E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655866(US20240067631, Compound 27)
Affinity DataEC50:  1.63E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655907(US20240067631, Compound 68)
Affinity DataEC50:  1.64E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655904(US20240067631, Compound 65)
Affinity DataEC50:  1.69E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655891(US20240067631, Compound 52)
Affinity DataEC50:  1.78E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655883(US20240067631, Compound 44)
Affinity DataEC50:  1.84E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655845(US20240067631, Compound 6)
Affinity DataEC50:  1.84E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655868(US20240067631, Compound 29)
Affinity DataEC50:  1.87E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655890(US20240067631, Compound 51)
Affinity DataEC50:  1.88E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655886(US20240067631, Compound 47)
Affinity DataEC50:  2.00E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655889(US20240067631, Compound 50)
Affinity DataEC50:  2.08E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655888(US20240067631, Compound 49)
Affinity DataEC50:  2.10E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655900(US20240067631, Compound 61)
Affinity DataEC50:  2.11E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655903(US20240067631, Compound 64)
Affinity DataEC50:  2.16E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655902(US20240067631, Compound 63)
Affinity DataEC50:  2.29E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Cytokinetics

US Patent
LigandPNGBDBM655885(US20240067631, Compound 46)
Affinity DataEC50:  2.35E+3nMAssay Description:Human Recombinant Enzyme Assay: Compounds described herein were assayed for their ability to stimulate the synthesis of nicotinamide mononucleotide (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
US Patent

Displayed 1 to 50 (of 145 total ) | Next | Last >>
Jump to: